The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Open accessAbstract
Potentially inappropriate medications (PIMs) continue to be prescribed and used as first-line treatment for the most vulnerable of older adults, despite evidence of poor outcomes from the use of PIMs in older adults. PIMs now form an integral part of policy and practice and are incorporated into several quality measures. The specific aim of this project was to update the previous Beers Criteria using a comprehensive, systematic review and grading of the evidence on drug-related problems and adverse drug events (ADEs) in older adults. This was accomplished through the support of The American Geriatrics Society (AGS) and the work of an interdisciplinary panel of 11 experts in geriatric care and pharmacotherapy who applied a modified Delphi method to the systematic review and grading to reach consensus on the updated 2012 AGS Beers Criteria. Fifty-three medications or medication classes encompass the final updated Criteria, which are divided into three categories: potentially inappropriate medications and classes to avoid in older adults, potentially inappropriate medications and classes to avoid in older adults with certain diseases and syndromes that the drugs listed can exacerbate, and finally medications to be used with caution in older adults. This update has much strength, including the use of an evidence-based approach using the Institute of Medicine standards and the development of a partnership to regularly update the Criteria. Thoughtful application of the Criteria will allow for (a) closer monitoring of drug use, (b) application of real-time e-prescribing and interventions to decrease ADEs in older adults, and (c) better patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, diphenhydramine, often taken as an over-the-counter drug combination with acetaminophen for sleep and pain relief; other sedative-hypnotics; and medications for anxiety (eg, benzodiazepines) or urinary incontinence (antimuscarinic) are relatively contraindicated in elderly and cognitively vulnerable persons.44,58”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The American Geriatrics Society (22) considers use of paroxetine for patients with impaired cognition to be potentially inappropriate because of the drug's strong anticholinergic properties.”
From Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors (2015) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Anticholinergic use was defined as those medications deemed to have strong anticholinergic activity as per consensus by an expert panel of health care professionals.8,13”
From Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study (2015) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We used the approach of Gray et al,11 which included drugs identified as having strong anticholinergic properties by the American Geriatrics Society 2012 Beers Criteria Update Expert Panel.14”
From Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study (2019) · cites this paper as [14]
In the citing paper
“The recently published 2012 Beers list of prohibited medications in long-term care facilities speci fi cally lists insulin sliding scales and glyburide as treatment modalities that should be avoided (61).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [61]
In the citing paper
“Glyburide has the highest hypoglycemia risk and should not be prescribed for older adults98.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Clinical Practice Guidelines We Can Trust
Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,146
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,171
Panel on Prevention of Falls in Older Persons, A. G. S. A. B. G. S. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.03234.x · Cited by 1,817
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J. M., DeBellis, K. R., Seger, A. C., Cadoret, C. A., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,666
Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.14.1531 · Cited by 1,568
Patterns of Functional Decline at the End of Life
Lunney, J. R. (2003) · JAMA · doi:10.1001/jama.289.18.2387 · Cited by 1,418
Beers, M. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.9.1825 · Cited by 1,325
Cited by
Sorted by citations
Items 801–900 of 1,003
Stabilizing and Managing Patients with Altered Mental Status and Delirium
Odiari, E. A., Sekhon, N., Han, J. Y., & David, E. H. (2015) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2015.07.004 · Cited by 29
Lo, A. X., & Harada, C. N. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.10.004 · Cited by 29
Narayan, S. W., & Nishtala, P. S. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12355 · Cited by 29
Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart
Elseviers, M. M., Stichele, R. V., & Bortel, L. M. V. (2013) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzt089 · Cited by 29
Tolerability of Antihypertensive Medications in Older Adults
Dharmarajan, T. S., & Dharmarajan, L. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0296-3 · Cited by 29
Juola, A.-L., Pylkkanen, S., Kautiainen, H., Bell, J. S., Bjorkman, M. P., Finne‐Soveri, H., Soini, H., & Pitkälä, K. H. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.12.011 · Cited by 30
Weiner, D. K., Fang, M. A., Gentili, A., Kochersberger, G. G., Marcum, Z. A., Rossi, M. I., Semla, T. P., & Shega, J. W. (2015) · Pain Medicine · doi:10.1111/pme.12757 · Cited by 29
Antidepressant-Associated Hyponatremia in the Elderly
Greenblatt, H. K., & Greenblatt, D. J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000608 · Cited by 29
Pluripatología, polifarmacia, complejidad terapéutica y uso adecuado de la medicación
Aguirre, N. G., Martínez, A. C., Muñoz, L. B., Avellana, M. C., Marcó, J., & Díez‐Manglano, J. (2017) · Revista Clínica Española · doi:10.1016/j.rce.2016.12.013 · Cited by 32
Brett, J., Elshaug, A. G., Bhatia, R. S., Chalmers, K., Badgery‐Parker, T., & Pearson, S. (2017) · Implementation Science · doi:10.1186/s13012-017-0585-9 · Cited by 29
Khaja, K. A. J. A., Isa, H. A., Veeramuthu, S., & Sequeira, R. P. (2018) · Medical Principles and Practice · doi:10.1159/000488055 · Cited by 28
Batko‐Szwaczka, A., Wilczyński, K., Hornik, B., Janusz-Jenczeń, M., Włodarczyk, I., Wnuk, B. R., Szołtysek, J., Durmała, J., Szuster-Kowolik, K., Antoniak-Sobczak, K., et al. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s256312 · Cited by 29
Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury
Leonard, C. E., Brensinger, C. M., Nguyen, T. P. P., Horn, J. R., Chung, S. P., Bilker, W. B., Dublin, S., Soprano, S. E., Dawwas, G. K., Oslin, D. W., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110531 · Cited by 29
Lagha, R. R., Burningham, Z. R., Sauer, B. C., Leng, J., Peters, C. B., Huynh, T., Patel, S. A., Halwani, A. S., & Kramer, B. J. (2020) · Applied Clinical Informatics · doi:10.1055/s-0040-1714693 · Cited by 30
Medication transitions: Vulnerable periods of change in need of human factors and ergonomics
Holden, R. J., & Abebe, E. (2020) · Applied Ergonomics · doi:10.1016/j.apergo.2020.103279 · Cited by 29
An examination of three prescribing cascades in a cohort of older adults with dementia
Trenaman, S., Bowles, S., Kirkland, S., & Andrew, M. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02246-2 · Cited by 26
An Update on Assessment, Therapeutic Management, and Patents on Insomnia
Porwal, A., Yadav, Y. C., Pathak, K., & Yadav, R. (2021) · BioMed Research International · doi:10.1155/2021/6068952 · Cited by 36
Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies.
Brunetti, L., & Kalabalik, J. (2012) · PubMed Central · Cited by 30
Drug Burden Index Score and Anticholinergic Risk Scale as Predictors of Readmission to the Hospital
Dispennette, R., Elliott, D. P., Nguyen, L. U., & Richmond, R. C. (2014) · The Consultant Pharmacist · doi:10.4140/tcp.n.2014.158 · Cited by 29
Developing a list of high-alert medications for patients with chronic diseases
Otero, M. J., Moreno-Gómez, A. M., Santos‐Ramos, B., & Agra, Y. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.10.021 · Cited by 29
Inappropriate prescribing in the elderly: A comparison of two validated screening tools
Karandikar, Y. S., Chaudhari, S., Dalal, N., Sharma, M., & Pandit, V. A. (2013) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2013.04.004 · Cited by 29
Blè, A., Masoli, J. A. H., Barry, H. E., Winder, R. E., Tavakoly, B., Henley, W., Kuchel, G. A., Valderas, J. M., Melzer, D. R., & Richards, S. H. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0143-8 · Cited by 32
Alcohol withdrawal syndrome in medical patients
Gortney, J. S., Raub, J. N., Patel, P. J., Kokoska, L., Hannawa, M., & Argyris, A. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.14061 · Cited by 29
on behalf of the Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ Project, Ponte, P. H., Torres, O. H., San‐José, A., Vidal, X., Agustí, A., Formiga, F., López‐Soto, A., Ramírez‐Duque, N., Fernández-Moyano, A., et al. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0452-z · Cited by 29
Academic Detailing with Provider Audit and Feedback Improve Prescribing Quality for Older Veterans
Vandenberg, A. E., Echt, K. V., Kemp, L., McGwin, G., Perkins, M. M., & Mirk, A. K. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15247 · Cited by 29
Thomas, R. E., Nguyen, L. T., Jackson, D., & Naugler, C. T. (2020) · Geriatrics · doi:10.3390/geriatrics5020037 · Cited by 29
Pinto, M. C. X., Malaquias, D. P., Ferré, F., & Pinheiro, M. L. P. (2013) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502013000400010 · Cited by 28
da Costa, I. H. F., Silva, R. M. E., Carlos, J. D. O., Silva, M. C. A., Pinheiro, M. K. C., Martins, B. C. C., Fernandes, P. F. C. B. C., & Guedes, M. M. (2019) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-019-00842-2 · Cited by 28
Conklin, J., Farrell, B., Ward, N., McCarthy, L. M., Irving, H. R., & Raman-Wilms, L. (2015) · Implementation Science · doi:10.1186/s13012-015-0279-0 · Cited by 33
de Groot, D. A., de Vries, M., Joling, K. J., van Campen, J. P. C. M., Hugtenburg, J. G., van Marum, R. J., den Tweel, A. M. A. V. W.-V., Elders, P. J. M., & van Hout, H. P. J. (2014) · Age and Ageing · doi:10.1093/ageing/afu075 · Cited by 28
Lisi, A. J., Breuer, P., Gallagher, R. M., Rodríguez, E., Rossi, M. I., Schmader, K. E., Scholten, J. D., & Weiner, D. K. (2015) · Pain Medicine · doi:10.1111/pme.12821 · Cited by 28
Drug interactions with antimalarial medications in older travelers: a clinical guide
Lewis, J., Gregorian, T., Portillo, I., & Goad, J. A. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz089 · Cited by 28
Varano, S., Staskin, D. R., Frankel, J. M., Shortino, D., Jankowich, R. A., & Mudd, P. N. (2021) · Drugs & Aging · doi:10.1007/s40266-020-00829-z · Cited by 30
Park, B., Baek, A., Kim, Y., Suh, Y., Lee, J., Lee, E., Lee, J., Lee, E., Lee, J.-C., Park, H. S., et al. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2021.06.005 · Cited by 29
Use of antithrombotics at the end of life: an in-depth chart review study
Huisman, B. A. A., Geijteman, E. C. T., Arévalo, J. J., Dees, M., van Zuylen, L., Szadek, K. M., van der Heide, A., & Steegers, M. A. H. (2021) · BMC Palliative Care · doi:10.1186/s12904-021-00786-3 · Cited by 28
Pharmacists’ Role in Older Adults’ Medication Regimen Complexity: A Systematic Review
Falch, C., & Alves, G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168824 · Cited by 28
Tao, L., Qu, X., Gao, H., Zhai, J., Zhang, Y., & Song, Y. (2021) · Medicine · doi:10.1097/md.0000000000027494 · Cited by 28
Paquin, A. M., Salow, M., & Rudolph, J. L. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13315 · Cited by 28
Chang, A., Fernandez, H. M., Cayea, D., Chheda, S. G., Paniagua, M. A., Eckstrom, E., & Day, H. D. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2752-2 · Cited by 30
Heppenstall, C. P., Broad, J., Boyd, M. L., Hikaka, J., Zhang, X., Kennedy, J., & Connolly, M. J. (2015) · Australian Journal on Ageing · doi:10.1111/ajag.12220 · Cited by 28
Pharmaceutical strategies towards optimising polypharmacy in older people
Hughes, C. M., Cadogan, C. A., Patton, D., & Ryan, C. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.035 · Cited by 28
El-Badawy, M. A. (2016) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000404 · Cited by 28
da Conceição, V. A., da Silva, D. T., de Santana, V. L., dos Santos, E. G., Santos, L. M. C., & de Lyra, D. P. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0164-3 · Cited by 28
Gorup, E. C., Rifel, J., & Šter, M. P. (2018) · Slovenian Journal of Public Health · doi:10.2478/sjph-2018-0018 · Cited by 29
Akhtar, A., Hassali, M. A., Zainal, H., Ali, I. A. H., Iqbal, M. S., & Khan, A. H. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620971141 · Cited by 27
Tomlinson, E., Schnitker, L., & Casey, P. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01122-z · Cited by 29
Harasani, K., García‐Caballos, M., Jucja, B., Casado-Fernández, E., Espigares, E., & Bueno‐Cavanillas, A. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-9943-8 · Cited by 27
Potentially inappropriate prescribing in elderly outpatients in Croatia
Popović, B., Quadranti, N. R., Matanović, S. M., Diminić-Lisica, I., Ljubotina, A., Duliba, D. P., & Vlahović–Palčevski, V. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1667-0 · Cited by 27
Prescribing for older patients with cancer.
Korc‐Grodzicki, B., Boparai, M. K., & Lichtman, S. M. (2014) · PubMed · Cited by 27
da Costa, F. A., Periquito, C., Carneiro, M. C., Oliveira, P., Fernandes, A. I., & Cavaco‐Silva, P. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0337-y · Cited by 27
Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homes
García‐Caballero, T., Lojo, J., Menéndez, C., Fernández-Álvarez, R., Mateos, R., & García-Caballero, A. A. (2018) · International Psychogeriatrics · doi:10.1017/s1041610217002411 · Cited by 27
Melatonin as a chronobiotic/cytoprotector: its role in healthy aging
Cardinali, D. P. (2018) · Biological Rhythm Research · doi:10.1080/09291016.2018.1491200 · Cited by 28
Lapointe‐Shaw, L., Bell, C. M., Austin, P. C., Abrahamyan, L., Ivers, N. M., Li, P., Pechlivanoglou, P., Redelmeier, D. A., & Dolovich, L. R. (2019) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-009545 · Cited by 27
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
Matt, S. M., & Gaskill, P. J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146398 · Cited by 26
Hashimoto, R., Fujii, K., Shimoji, S., Utsumi, A., Hosokawa, K., Tochino, H., Sanehisa, S., Akishita, M., & Onda, M. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13850 · Cited by 27
Leguelinel, G., Castelli, C., Rolain, J., Bouvet, S., Chkair, S., Kabani, S., Jalabert, B., Rouvière, S., Choukroun, C., Richard, H., et al. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1707082 · Cited by 27
Bony, H., Lloyd, R. A., Hotham, E. D., Corre, L., Corlis, M. E., Loffler, H., Scarlett, G., Tsimbinos, J. M., Todd, I. P., & Suppiah, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-66991-x · Cited by 28
Attal, N. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.07.003 · Cited by 27
Hall, R. K., Blumenthal, J. B., Doerfler, R. M., Chen, J., Diamantidis, C. J., Jaar, B. G., Kusek, J. W., Kallem, K., Leonard, M. B., Navaneethan, S. D., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.03.019 · Cited by 27
Wang, G. H., Man, K. K. C., Chang, W. H., Liao, T., & Lai, E. C. (2021) · BMJ · doi:10.1136/bmj.n1925 · Cited by 27
A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
David, P. S., Smith, T. L., Nordhues, H. C., & Kling, J. M. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s282396 · Cited by 28
“Additionally, long-term use of anticholinergic medications may be associated with cognitive effects and contribute to medication interactions, especially in elderly patients.(52) A recent systematic review of medications used for overactive bladder has shown an association between cognitive decline and oxybutynin use,…”
BackgroundDíez, R., Cadenas, R., Susperregui, J., Sahagún, A. M., Fernández, N., Garcia, J. J., Sierra, M., & López, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133808 · Cited by 29
Undela, K., Bansal, D., D’Cruz, S., Sachdev, A., & Tiwari, P. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12081 · Cited by 27
Management of Chronic Spontaneous Urticaria in the Elderly
Ventura, M. T., Cassano, N., Romita, P., Vestita, M. G., Foti, C., & Vena, G. A. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0249-x · Cited by 27
“American Geriatrics Society updated Beers list of potentially inappropriate medications for older adults [70].”
BackgroundCarrière, I., Mura, T., Pérès, K., Norton, J. L., Jaussent, I., Edjolo, A., Rouaud, O., Berr, C., Ritchie, K. A., & Ancelin, M. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.10.006 · Cited by 27
Extending the ABCDE Bundle to the Post-Intensive Care Unit Setting
Balas, M. C., Buckingham, R. B., Braley, T., Saldi, S., & Vasilevskis, E. E. (2013) · Journal of Gerontological Nursing · doi:10.3928/00989134-20130530-06 · Cited by 27
Meize‐Grochowski, R., Shuster, G. F., Boursaw, B., DuVal, M., Murray-Krezan, C. M., Schrader, R., Smith, B. W., Herman, C. J., & Prasad, A. (2015) · Geriatric Nursing · doi:10.1016/j.gerinurse.2015.02.012 · Cited by 27
Receipt of High Risk Medications among Elderly Enrollees in Medicare Advantage Plans
Qato, D. M., & Trivedi, A. N. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2244-9 · Cited by 27
Moreno‐Gutiérrez, P. A., Gaviria‐Mendoza, A., Montoya-Cañón, M., & Machado‐Alba, J. E. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12969 · Cited by 28
Desnoyer, A., Guignard, B., Lang, P. O., Desmeules, J. A., Vogt-Ferrier, N., & Bonnabry, P. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.06.033 · Cited by 28
Hannou, S., Voirol, P., Pannatier, A., Weibel, M.-L., Sadeghipour, F., von Gunten, A., Mall, J., & Giorgi, I. D. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0513-8 · Cited by 27
Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillation.
Bo, M., & Marchionni, N. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.10.026 · Cited by 27
Polypharmacy: Geriatric Oncology Evaluation Should Become Mainstream
Lichtman, S. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.3548 · Cited by 27
Ganassin, A. R., Gubert, V. T., & Toffoli-Kadri, M. C. (2014) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502014000400018 · Cited by 26
“…Index (Hanlon et al., 1992), the STOPP/START criteria (Gallagher et al., 2008), the PRISCUS list (Holt, Schmield, Petra, 2010), the Korean list (Kim, Heo, Lee, 2010), IPET (Naugler et al., 2000) and Beers Criteria (Beers et al., 1991; Beers, 1997; Fick et al., 2003; Fick et al., 2012).”
BackgroundMethodPugh, M. J., Marcum, Z. A., Copeland, L. A., Mortensen, E. M., Zeber, J. E., Noël, P. H., Berlowitz, D. R., Downs, J. R., Good, C. B., Álvarez, C. A., et al. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0086-8 · Cited by 26
Suehs, B. T., Davis, C. D., Franks, B., Yuran, T. E., Ng, D., Bradt, J., Knispel, J., Vassilakis, M. E., & Berner, T. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14030 · Cited by 26
Beverly, E. A., Ritholz, M. D., Shepherd, C., & Weinger, K. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0741-7 · Cited by 31
Schmedt, N., Kollhorst, B., Enders, D., Jobski, K., Krappweis, J., Garbe, E., & Schink, T. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.07.006 · Cited by 26
Nguyen, T. A., Pham, T., Vu, H. T. T., Nguyen, T. X., Vu, T. T., Nguyen, B. T., Nguyen, B. T., Nguyen, T. N., Nguyen, B. T., Nguyen, A. T., et al. (2018) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317518768999 · Cited by 25
Sarwar, M. R., Iftikhar, S., & Sarfraz, M. (2018) · Medicina · doi:10.3390/medicina54040057 · Cited by 26
Wang-Hansen, M. S., Wyller, T. B., Hvidsten, L., & Kersten, H. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02624-1 · Cited by 26
The medicalization of sleeplessness: Results of U.S. office visit outcomes, 2008–2015
Moloney, M., Ciciurkaite, G., & Brown, R. L. (2019) · SSM - Population Health · doi:10.1016/j.ssmph.2019.100388 · Cited by 26
Fujie, K., Kamei, R., Araki, R., & Hashimoto, K. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-00967-9 · Cited by 26
Machado, F. V., Louzada, L. L., Cross, N. E., Camargos, E. F., Dang‐Vu, T. T., & Nóbrega, O. D. T. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110962 · Cited by 28
Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults
Sugidono, M. D. S., Lo, M., Young, R., Rosario, K., Jung, Y., Huang, C., Sheng, Y., Huang, L., & Olin, R. L. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.01.001 · Cited by 26
Noh, H., Song, H. J., Park, Y. S., Han, J., & Roh, Y. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-81034-9 · Cited by 26
Berk, M., Agustini, B., Woods, R. L., Nelson, M. R., Shah, R. C., Reid, C. M., Storey, E., Fitzgerald, S. M., Lockery, J. E., Wolfe, R. S., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01020-5 · Cited by 27
Lee, H., Chong, J., Jung, H., Baek, J. Y., Lee, E., & Jang, I. (2021) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.20.0095 · Cited by 26
Gundersen, E. C., & Bensadon, B. A. (2023) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2022.10.010 · Cited by 31
Cognition in Late-Life Depression: Treatment Considerations
Koenig, A. M., & Butters, M. A. (2013) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-013-0001-2 · Cited by 27
Maust, D. T., Oslin, D. W., & Marcus, S. C. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12640 · Cited by 26
Rural‐Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians
Goeres, L. M., Gille, A., Furuno, J. P., Erten‐Lyons, D., Hartung, D. M., Calvert, J. F., Ahmed, S. M., & Lee, D. S. H. (2015) · The Journal of Rural Health · doi:10.1111/jrh.12153 · Cited by 26
Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting
Gyawali, B., Poudyal, B. S., & Iddawela, M. Y. (2016) · Journal of Global Oncology · doi:10.1200/jgo.2015.002477 · Cited by 26
Skinder, D., Zacharia, I., Studin, J., & Covino, J. M. (2016) · JAAPA · doi:10.1097/01.jaa.0000488689.58176.0a · Cited by 26
Salisbury, C., Man, M., Chaplin, K., Mann, C., Bower, P., Brookes, S. T., Duncan, P., Fitzpatrick, B., Gardner, C., Gaunt, D., et al. (2019) · Health Services and Delivery Research · doi:10.3310/hsdr07050 · Cited by 26
Balancing medication use in nursing home residents with life-limiting disease
Paque, K., Elseviers, M. M., Stichele, R. V., Pardon, K., Vinkeroye, C., Deliëns, L., Christiaens, T., & Dilles, T. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02649-6 · Cited by 26
Chatterjee, S., Bali, V., Carnahan, R. M., Chen, H., Johnson, M. L., & Aparasu, R. R. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.05.020 · Cited by 26
Mixon, A. S., Neal, E. B., Bell, S. P., Powers, J. S., & Kripalani, S. B. (2014) · Gerontology · doi:10.1159/000363765 · Cited by 27
The growing problem of co-treatment with opioids and benzodiazepines
Karaca‐Mandic, P., Meara, E. R., & Morden, N. E. (2017) · BMJ · doi:10.1136/bmj.j1224 · Cited by 26
Application of light therapy in older adults with cognitive impairment: a systematic review
Cibeira, N., Maseda, A., Lorenzo-López, L., Rodríguez-Villamil, J. L., López-López, R., & Millán-Calenti, J. C. (2020) · Geriatric Nursing · doi:10.1016/j.gerinurse.2020.07.005 · Cited by 25
Metadata
- Authors
- The American Geriatrics Society 2012 Beers Criteria Update Expert Panel
- Affiliations
- American Geriatrics Society (US)
- Corresponding author
- The American Geriatrics Society 2012 Beers Criteria Update Expert Panel
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2012-02-29
- Volume
- 60
- Issue
- 4
- Pages
- 616-631
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- PMC
- PMC3571677
- OpenAlex
- W2257575319
- Cited by
- 2,578
- References
- 44
- Citations by year
- 2026: 20 · 2025: 37 · 2024: 37 · 2023: 60 · 2022: 54 · 2021: 256 · 2020: 298 · 2019: 194 · 2018: 163 · 2017: 213 · 2016: 300 · 2015: 344 · 2014: 305 · 2013: 207 · 2012: 86
- FWCI
- 25.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5k07ag033174-05)
- Agency for Healthcare Research and Quality (R01HS017695, R01HS018721)
- National Institute on Aging (R01AG027017, K07‐AG033174, R01AG034056, P30AG024827, T32AG021885)
- National Institute of Nursing Research (R01NR010135, R01NR011042, R01NR012242)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- Beers criteria, potentially inappropriate medications, older adults, drug-related problems, adverse drug reactions, drug safety, Delphi consensus, level of evidence, quality metrics
- MeSH terms
- Aged, Geriatrics, Humans, Medication Errors, Practice Patterns, Physicians', Drug Prescriptions, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
